Virios Therapeutics Inc.
13F holders, Q3 2024 (September 30)24holders
4new positions
4sold out
1famous investor
$0.17avg. 13F price*
At the end of Q3 2024, 24 institutions reported holding Virios Therapeutics Inc. in their 13F filings, unchanged from Q2 2024. 4 opened new positions and 4 sold out. The largest holders were Geode Capital Management, LLC ($39K), Vanguard Group Inc. ($36K) and UBS Group AG ($32K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Virios Therapeutics Inc.
- CUSIP
- 92829J104
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $17K |
| Exits | 4 | $26K |
All 13F filers, Q2 2024 → Q3 2024: 223,491 shares bought and 145,419 shares sold, net +78,072 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Geode Capital Management, LLC | 0.00% | Add +32.3% | 230,750 | $39K |
| Vanguard Group Inc. | 0.00% | No change | 208,883 | $36K |
| UBS Group AG | 0.00% | Add +22.6% | 186,062 | $32K |
| HRT Financial LP | 0.00% | Add +41.8% | 81,574 | $13K |
| Two Sigma Securities, LLC | 0.00% | New | 53,392 | $9K |
| State Street Corp. | 0.00% | No change | 52,828 | $9K |
| McCollum Christoferson Group LLC | 0.00% | Reduce -41.2% | 33,500 | $6K |
| Raymond James & Associates | 0.00% | Add +2.0% | 30,600 | $5K |
| Jane Street Group, LLC | 0.00% | New | 28,032 | $5K |
| Northern Trust Corp. | 0.00% | No change | 24,035 | $4K |
| Regions Financial Corp. | 0.00% | No change | 20,072 | $3K |
| One Plus One Wealth Management, LLC | 0.00% | Add +100.0% | 20,000 | $3K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 19,062 | $3K |
| Renaissance Technologies | 0.00% | New | 16,500 | $3K |
| Morgan Stanley | 0.00% | Add +1.3% | 15,201 | $3K |
| William Howard & Co Financial Advisors Inc | 0.00% | No change | 10,072 | $2K |
| &partners | 0.00% | No change | 11,000 | $2K |
| Cetera Investment Advisers | 0.00% | Reduce -11.1% | 10,582 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.8% | 6,823 | $1K |
| Activest Wealth Management | 0.00% | No change | 3,000 | $510 |
| Group One Trading LLC | 0.00% | No change | 1,297 | $220 |
| BlackRock, Inc. | 0.00% | — | 755 | $128 |
| Bank of America Corp. | 0.00% | Add +51.8% | 211 | $36 |
| Simplex Trading, LLC | 0.00% | New | 100 | $0 |
"% of holder's portfolio" is VIRIOS THERAPEUTICS INC's weight in each manager's 13F, not the share of Virios Therapeutics Inc. the manager owns.